Atlas Trials

Chinese Multiple Dose Escalation (MDE) High Dose Study

Clinical trial NCT05437848 · COMPLETED

Trial details

NCT number
NCT05437848
Sponsor
AstraZeneca
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Diabetes
Start date
2022-02-25
Primary completion
2022-12-12
Enrollment
16

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.